PARIS, France—Two studies presented at EuroPCR 2019 provide some reassurances that the newer-generation MitraClip XTR (Abbott), which features longer arms for grasping and increased maneuverability, ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

A retrospective study led by researchers from Penn Medicine found that with MitraClip for treatment of secondary mitral regurgitation (MR), a heart disease associated with problems in the left ...

Failed transcatheter edge-to-edge repair of functional and degenerative mitral regurgitation (MR) with the MitraClip (Abbott) is relatively uncommon at high-volume centers but associated with a high ...

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — “a Class I recall, the most serious type,” the FDA said. “Use of this device may cause serious injuries or death ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A little device is about to make a big difference in millions of lives. Mitral regurgitation occurs when the valve that separates the main pumping chamber of the heart from the lungs is unable to ...

SAN DIEGO, CA (UPDATED)—It’s a shocking success for the MitraClip after years of gloomy predictions, sluggish trial enrollment, and—most of all—the negative MITRA-FR trial results last month. Today, ...